Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy
ABSTRACTAlthough immune checkpoint inhibitor (ICI) therapy has dramatically improved outcome for metastatic melanoma patients, many patients do not benefit. Since adverse events may be severe, biomarkers for resistance would be valuable, especially in the adjuvant setting. We performed high-plex dig...
Main Authors: | Sandra Martinez-Morilla, Myrto Moutafi, Aileen I. Fernandez, Shlomit Jessel, Prajan Divakar, Pok Fai Wong, Rolando Garcia-Milian, Kurt A. Schalper, Harriet M. Kluger, David L. Rimm |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2260618 |
Similar Items
-
Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma
by: Kostas Palamaris, et al.
Published: (2022-03-01) -
A Novel Dentary Bone Conduction Device Equipped with Laser Communication in DSP
by: Jau-Woei Perng, et al.
Published: (2021-06-01) -
The abscopal effect of anti-CD95 and radiotherapy in melanoma
by: Jixiang Xu, et al.
Published: (2023-05-01) -
Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells
by: Thuy T. Tran, et al.
Published: (2021-03-01) -
Screening for Melanoma and Other Skin Cancer Shows a Higher Early Melanoma Incidence: Social Educational Program “Life Fear-Free”
by: Lev Demidov, et al.
Published: (2021-03-01)